Ventriculovascular couping in systolic and diastolic heart failure

Current Cardiology Reports

Volumn 8, Issue 3, 2006, Pages 232-239

  Fox, Justin M ^b   Maurer, Mathew S ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALAGEBRIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM; PLACEBO; VERAPAMIL;

BLOOD PRESSURE; CLINICAL TRIAL; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TARGETING; HEART FAILURE; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART STROKE VOLUME; HUMAN; HYPERTENSION; LONG TERM CARE; LUNG EDEMA; NON INVASIVE MEASUREMENT; NONHUMAN; PATHOPHYSIOLOGY; PRESSURE VOLUME CURVE; REVIEW; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 33646420393     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0039-5     Document Type: Review

References (61)

1. Kumar A, Anel R, Bunnell E, et al.: Preload-independent mechanisms contribute to increased stroke volume following large volume saline infusion in normal volunteers: a prospective interventional study. Crit Care 2004, 3:R128-R136.
2. Bellenger NG, Burgess MI, Ray SG, et al.: Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000, 21:1387-1396.
3. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K: Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983, 245 (Suppl 5, Pt 1): H773-H780.
4. Burkhoff D, Sagawa K: Ventricular efficiency predicted by an analytical model. Am J Physiol 1986, 250(Suppl 6, Pt 2): R1021-R1027.
5. Sunagawa K, Sagawa K, Maughan WL: Ventricular interaction with the loading system. Ann Biomed Eng 1984, 12:163-189.
6. Sunagawa K, Maughan WL, Sagawa K: Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 1985, 56:586-595.
7. Kelly RP, Ting CT, Yang TM, et al.: Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992, 86:513-521.
8. Starling MR: Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993, 125:1659-1666.
9. Asanoi H, Sasayama S, Kameyama T: Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989, 65:483-493.
10. Najjar SS, Schulman SP, Gerstenblith G, et al.: Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol 2004, 44:611-617.
11. Fleg JL, O'Connor F, Gerstenblith G, et al.: Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995, 78:890-900.
12. Nichols WW, O'Rourke MF, Avolio AP, et al.: Effects of age on ventricular-vascular coupling. Am J Cardiol 1985, 55:1179-84.
13. Vaitkevicius PV, Fleg JL, Engel JH, et al.: Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993, 88(Suppl 4, Pt 1):1456-1462.
14. Saba PS, Roman MJ, Ganau A, et al.: Relationship of effective arterial elastance to demographic and arterial characteristics in normotensive and hypertensive adults. J Hypertens 1995, 13:971-977.
15. Cohen-Solal A, Caviezel B, Laperche T, Gourgon R: Effects of aging on left ventricular-arterial coupling in man: assessment by means of arterial effective and left ventricular elastances. J Hum Hypertens 1996, 10:111-116.
16. Chen CH, Nakayama M, Nevo B, et al.: Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 1998, 32:1221-1227.
17. Baan J, Jong TT, Kerkhof PL, et al.: Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res 1981, 15:328-334.
18. Burkhoff D, van der Velde E, Kass D, et al.: Accuracy of volume measurement by conductance catheter in isolated, ejecting canine hearts. Circulation 1985, 72:440-447.
19. Kass DA, Yamazaki T, Burkhoff D, et al.: Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 1986, 73:586-595.
20. Kass DA, Midei M, Graves W, et al.: Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 1988, 15:192-202.
21. Chemla D, Antony I, Lecarpentier Y, Nitenberg A: Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans. Am J Physiol Heart Circ Physiol 2003 August, 285:H614-H620.
22. Sharir T, Feldman MD, Haber H, et al.: Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power. Validation and noninvasive application. Circulation 1994, 89:2045-2053.
23. Chen CH, Nakayama M, Talbot M, et al.: Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. J Am Coll Cardiol 1999, 33:1602-1609.
24. Saba PS, Ganau A, Devereux RB, et al.: Impact of arterial elastance as a measure of vascular load on left ventricular geometry in hypertension. J Hypertens 1999, 17:1007-1015.
25. Maurer MS, King DL, El-Khoury RL, et al.: Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 2005, 11:177-187.
26. Shishido T, Hayashi K, Shigemi K, et al.: Single-beat estimation of end-systolic elastance using bilinearly approximated time-varying elastance curve. Circulation 2000, 102:1983-1989.
27. Takeuchi M, Igarashi Y, Tomimoto S, et al.: Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 1991, 83:202-212.
28. Senzaki H, Chen CH, Kass DA: Single-beat estimation of end-systolic pressure-volume relation in humans. A new method with the potential for noninvasive application. Circulation 1996, 94:2497-2506.
29. Lee DS, Kim KM, Kim SK, et al.: Development of a method for measuring myocardial contractility with gated myocardial SPECT and arterial tonometry. J Nucl Cardiol 1999, 6:657-663.
30. Lee WS, Nakayama M, Huang WP, et al.: Assessment of left ventricular end-systolic elastance from aortic pressure-left ventricular volume relations. Heart Vessels 2002, 16:99-104.
31. Chen CH, Fetics B, Nevo E, et al.: Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001, 38:2028-2034.
32. Hunt SA, Baker DW, Chin MH, et al.: ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001, 104:2996-3007.
33. Bristow MR: Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997, 80:26L-40L.
34. Reiken S, Gaburjakova M, Gaburjakova J, et al.: Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 2001, 104:2843-2848.
35. Yasumura Y, Takemura K, Sakamoto A, et al.: Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure. J Card Fail 2003, 9:469-474.
36. Cohen-Solal A, Faraggi M, Czitrom D, et al.: Left ventricular-arterial system coupling at peak exercise in dilated nonischemic cardiomyopathy. Chest 1998, 113:870-877.
37. Ohte N, Cheng CP, Little WC: Tachycardia exacerbates abnormal left ventricular-arterial coupling in heart failure. Heart Vessels 2003, 18:136-141.
38. Maurer MS: Hemodynamic mechanisms of ejection fraction improvement with chronic carvedilol treatment in heart failure:insights from three-dimensional echocardiography [abstract]. J Am Coll Cardiol 2003, 41(Suppl A):218A.
39. Lechat P: Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study. J Cardiovasc Pharmacol 1990, 16(Suppl 5):S158-S163.
40. Lechat P: Beta-blocker treatment in heart failure: Role of heart rate reduction. Basic Res Cardiol 1998, 93 (Suppl 1):148-155.
41. Lechat P, Hulot JS, Escolano S, et al.: Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001, 103:1428-1433.
42. Genth-Zotz S, Zotz RJ, Sigmund M, et al.: MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing. Eur J Heart Fail 2000, 2:175-181.
43. Maurer MS, Wajahat R, King DL, Burkhoff D: Ventricular pump function in patients with heart failure: stroke work and its relation to myocardial mass [abstract]. J Card Fail 2005, 11:S112.
44. Burkhoff D, Maurer MS, Packer M: Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003, 107:656-658.
45. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002, 105:1503-1508.
46. Klapholz M, Maurer M, Lowe AM, et al.: Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004, 43:1432-1438.
47. Nitenberg A, Antony I, Loiseau A: Left ventricular contractile performance, ventriculoarterial coupling, and left ventricular efficiency in hypertensive patients with left ventricular hypertrophy. Am J Hypertens 1998, 11:1188-1198.
48. Cohen-Solal A, Caviezel B, Himbert D, Gourgon R: Left ventricular-arterial coupling in systemic hypertension: analysis by means of arterial effective and left ventricular elastances. J Hypertens 1994, 12:591-600.
49. Kawaguchi M, Hay I, Fetics B, Kass DA: Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107:714-720.
50. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH: Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005, 111:2306-2312.
51. Kitzman DW: Diastolic heart failure in the elderly. Heart Fail Rev 2002, 7:17-27.
52. Gandhi SK, Powers JC, Nomeir AM, et al.: The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344:17-22.
53. Burkhoff D, Tyberg JV: Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis. Am J Physiol 1993, 265(Suppl 5, Pt 2):H1819-H1828.
54. Hay I, Rich J, Ferber P, et al.: Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol 2005, 288: H1203-H1208.
55. Santamore WP, Burkhoff D: Hemodynamic consequences of ventricular interaction as assessed by model analysis. Am J Physiol 1991, 260(Suppl 1, Pt 2):H146-H157.
56. Nussbacher A, Gerstenblith G, O'Connor FC, et al.: Hemodynamic effects of unloading the old heart. Am J Physiol 1999, 277(Suppl 5, Pt 2):H1863-H1871.
57. Haber HL, Simek CL, Bergin JD, et al.: Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance. J Am Coll Cardiol 1993, 22:251-257.
58. Vaitkevicius PV, Lane M, Spurgeon H, et al.: A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A 2001, 98:1171-1175.
59. Kass DA, Shapiro EP, Kawaguchi M, et al.: Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104:1464-1470.
60. Bakris GL, Bank AJ, Kass DA, et al.: Advanced glycation end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 2004, 17(Suppl 12, Pt 2):23S-30S.
61. Little WC, Zile MR, Kitzman DW, et al.: The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 2005, 11:191-195.